Sharpstone Capital

Sharpstone sources proprietary deal flow by acting first as a paid advisory firm securing non-dilutive French innovation financing — Bpifrance grants, recoverable advances, research tax credits — for technology startups. The firm's website states it invests equity only in companies that have already completed an advisory engagement with Sharpstone, turning the grant-application process into a de facto diligence and screening period before it commits capital.

Sharpstone operates as both, but structurally it is an advisory-first business. The advisory practice handles non-dilutive and private financing strategy for seed through IPO-stage companies; its website claims more than 500 clients. The investment activity is described as minority co-investment reserved for projects that first passed through the advisory pipeline, without any published fund vehicle, LP base, or discrete fund size.

The firm's published advisory and capital engagements span FinTech, HR and EdTech, BioTech, MedTech, Space Tech, and deep tech generally. Its content marketing emphasizes deeptech dilution management and government financing strategy, reflecting a concentration in capital-intensive sectors where French public funding instruments are most material.

Sharpstone describes its equity practice as taking minority co-investment positions in startups it previously advised. There is no public disclosure of fund-of-fund commitments, club deals, or SPV participation alongside external general partners. The model appears self-contained: advisory clients are the exclusive pool from which equity investments are drawn.

Sharpstone does not disclose a fundraising vehicle, limited partners, or an external capital base. The equity capital deployed is likely sourced from the firm's principals' balance sheet and retained advisory fee income, consistent with a model that uses the consultancy's cash flows to fund selective minority positions rather than raising a blind pool from third-party investors.